Live

pharmaceutical industry

3 articles

Merck to Acquire Terns Pharma for $6B, Bolstering Oncology Pipeline Before Keytruda Patent Cliff

Benzinga

Benzinga·Mar 25·Tanya Rawat

Merck to Acquire Terns Pharma for $6B, Bolstering Oncology Pipeline Before Keytruda Patent Cliff

Merck pursues $6B acquisition of Terns Pharma to strengthen oncology pipeline as Keytruda faces patent expiration amid broader $320B industry revenue cliff.

MRKNVSTERNacquisitionM&A

Can Veeva Systems Deliver Multimillion-Dollar Returns? Long-Term Growth Prospects Examined

The Motley Fool

The Motley Fool·Mar 14·Prosper Junior Bakiny

Can Veeva Systems Deliver Multimillion-Dollar Returns? Long-Term Growth Prospects Examined

Veeva Systems delivered 13.6% CAGR returns since 2013 IPO. Strong competitive advantages and $20B addressable market could support multimillion-dollar returns, but growth is slowing amid increasing competition.

VEEVcloud computingrevenue growth

Global Pharmacovigilance Market to Expand Threefold to $24.69B by 2035

GlobeNewswire Inc.

GlobeNewswire Inc.·Feb 25·Sns Insider

Global Pharmacovigilance Market to Expand Threefold to $24.69B by 2035

Pharmacovigilance market projected to grow threefold from $8.91B (2025) to $24.69B (2035), driven by stricter regulations and rising adverse drug reactions globally.

ORCLORCLpDACNIQVVEEV+1regulatory compliancerisk management